| Financial Year |
March 31 2023 |
| Monetary Funds |
16,091,732,551.77 |
| Held-for-trading Financial Assets |
1,966,547,565.40 |
| Notes Receivable |
-- |
| Accounts Receivable |
80,318,902.48 |
| Advances to Suppliers |
121,447,763.66 |
| Other Receivables |
130,475,733.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,052,804,736.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
112,736,624.71 |
| Total Current Assets |
28,119,185,622.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,873,184.12 |
| Investment Properties |
13,174,022.83 |
| Fixed Assetes |
2,997,444,991.20 |
| Under-construction Projects |
2,723,836,904.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,099,474,833.03 |
| R&D expenses |
-- |
| Goodwill |
561,364,385.01 |
| Long-Term Deferred and Prepaid Expenses |
51,917,985.29 |
| Deferred Income Tax Assets |
648,805,808.21 |
| Other Non-Current Assets |
1,434,000.00 |
| Sub-Total of Non-Current Assets |
8,195,428,292.76 |
| Total Assets |
36,314,613,914.84 |
| Short-Term Loans |
6,666,621.85 |
| Trading Financial liabilities |
-- |
| Notes Payable |
738,520,000.00 |
| Accounts Payable |
2,019,189,027.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
906,388,708.37 |
| Taxes Payable |
1,290,597,847.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,171,080,476.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
41,889,105.49 |
| Other Current Liabilities |
1,973,107,310.70 |
| Sub-Total of Current Liabilities |
14,892,509,293.46 |
| Long-term Loans |
100,001,036.52 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
291,296,893.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
510,446,875.79 |
| Total Liabilities |
15,402,956,169.25 |
| Paid-In Capital(Or Share Stock) |
528,600,000.00 |
| Capital Surplus |
6,224,747,667.10 |
| Surplus Reserve |
269,402,260.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
13,067,303,476.06 |
| Minority Stockholder's Interest |
840,066,390.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,071,591,354.73 |
| Owner's Equity（Stockholder's Equity） |
20,911,657,745.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
36,314,613,914.84 |
